Literature DB >> 17149382

Drug insight: testosterone preparations.

Upendram Srinivas-Shankar1, Frederick C W Wu.   

Abstract

Testosterone has been used for substitution therapy in testicular and hypothalamopituitary diseases for almost six decades, with injectable testosterone esters and implanted testosterone pellets being the mainstay of treatment. Growing interest in the possible use of testosterone in nonclassical situations such as male contraception, aging (late-onset hypogonadism), muscle-wasting conditions like HIV, erectile dysfunction, and female hypoactive sexual disorder has stimulated research, leading to the development of several new modes of administration of testosterone. Transdermal patches, gels, mucoadhesive sustained-release buccal tablets and long-acting testosterone esters are designed to provide testosterone levels that approximate normal physiologic levels, to improve patient acceptability, and to further increase the number of treatment options available. In this Review, we briefly describe the chemistry, mechanism of action, and metabolism of testosterone. We then discuss the pharmacokinetics, advantages, and disadvantages of various formulations and summarize the various preparations currently available.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17149382     DOI: 10.1038/ncpuro0650

Source DB:  PubMed          Journal:  Nat Clin Pract Urol        ISSN: 1743-4270


  14 in total

1.  National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Authors:  Robert D Kersey; Diane L Elliot; Linn Goldberg; Gen Kanayama; James E Leone; Mike Pavlovich; Harrison G Pope
Journal:  J Athl Train       Date:  2012 Sep-Oct       Impact factor: 2.860

2.  The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.

Authors:  James T Dalton; Kester G Barnette; Casey E Bohl; Michael L Hancock; Domingo Rodriguez; Shontelle T Dodson; Ronald A Morton; Mitchell S Steiner
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-08-02       Impact factor: 12.910

Review 3.  Androgen receptor variation affects prostate cancer progression and drug resistance.

Authors:  Edel McCrea; Tristan M Sissung; Douglas K Price; Cindy H Chau; William D Figg
Journal:  Pharmacol Res       Date:  2016-10-07       Impact factor: 7.658

Review 4.  The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.

Authors:  Marià Alemany
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

Review 5.  Urologic complications of HIV and AIDS.

Authors:  Chris F Heyns; Adam E Groeneveld; Nelson B Sigarroa
Journal:  Nat Clin Pract Urol       Date:  2009-01

Review 6.  Advances in male contraception.

Authors:  Stephanie T Page; John K Amory; William J Bremner
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 7.  Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer.

Authors:  Navid Sobhani; Daniele Generali; Alberto D'Angelo; Michele Aieta; Giandomenico Roviello
Journal:  Invest New Drugs       Date:  2018-08-07       Impact factor: 3.850

Review 8.  Can conditions of skeletal muscle loss be improved by combining exercise with anabolic-androgenic steroids? A systematic review and meta-analysis of testosterone-based interventions.

Authors:  Hugo Falqueto; Jorge L R Júnior; Mauro N O Silvério; Juliano C H Farias; Brad J Schoenfeld; Leandro H Manfredi
Journal:  Rev Endocr Metab Disord       Date:  2021-03-30       Impact factor: 6.514

9.  Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: A prospective cohort study (ENIGI).

Authors:  Justine Defreyne; Yuran Vanwonterghem; Sarah Collet; Sean J Iwamoto; Chantal M Wiepjes; Alessandra D Fisher; Thomas Schreiner; Martin Den Heijer; Guy T'Sjoen
Journal:  Int J Transgend Health       Date:  2020-02-12

Review 10.  Late-onset hypogonadism: Clinical evidence, biological aspects and evolutionary considerations.

Authors:  Nikolai Jaschke; Andrew Wang; Lorenz C Hofbauer; Martina Rauner; Tilman D Rachner
Journal:  Ageing Res Rev       Date:  2021-02-18       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.